Sonoma Pharmaceuticals, Inc. (SNOA) Tops Q3 EPS by 13c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $3.14 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• CCHH signs $50M data center services deal in Malaysia
• DA Davidson Reiterates Neutral Rating on Fastenal (FAST), Says Would Buy on 'Any Meaningful Retrenchment'